SYK Stryker Corporation Earnings per share for the last twelve months

Corporate company logo of Stryker Corp (SYK)

Stryker Corporation (SYK) TTM fundamental earnings per share demonstrate the company's growth strategy through the systematic acquisition of tech startups. Business stability is supported by the defensive qualities of medtech, where economic fluctuations have almost no impact on demand. The current 9.42 metric determines the status of the yield parameter. Leadership in orthopedics and the Mako robotic system create a powerful barrier for competitors due to the complexity of physician retraining.

Stryker Corporation (SYK) - Net earnings per share (EPS TTM) from 07/04/2022 to 11/17/2026

Analytical breakdowns for Stryker Corporation Inc. (SYK)

Initial company analysis:Stryker Corporation Inc. (SYK)
Flagship merchandise of Stryker Inc

Stryker Corporation (SYK) leadership in robotic and neurosurgery directly impacts net income per common share. This metric measures the actual efficiency of capital generation over the year, adjusted for dilution, which allows for an assessment of the business's margin resilience against logistics costs and innovation expenditures via the rolling 12-month earnings per share.